Navigation Links
U.S. Market for Interventional Cardiology Devices
Date:2/5/2013

/>9.5 COMPETITIVE ANALYSIS 141
CORONARY EMBOLIC PROTECTION DEVICE MARKET..144
10.1 INTRODUCTION 144
10.1.1 Saphenous Vein Grafts .144
10.1.2 Protection Mechanism..145
10.1.2.1 Filter Basket .145
10.1.2.2 Distal Balloon Occlusion 145
10.2MARKET ANALYSIS & FORECAST ..146
10.2.1 Penetration Rate.148
10.3 DRIVERS AND LIMITERS ..151
10.3.1 Market Drivers .151
10.3.2 Market Limiters 151
10.4 COMPETITIVE ANALYSIS .153
CORONARY ATHERECTOMY DEVICE MARKET..156
11.1 INTRODUCTION 156
11.1.1 Atherectomy..156
11.1.2 Device Technologies.157
11.1.2.1 Mechanical Atherectomy.157
11.1.2.2 Laser Atherectomy.157
11.1.2.3 Directional Coronary Atherectomy (DCA) 157
11.2MARKET OVERVIEW.158
11.3MARKET ANALYSIS & FORECAST ..160
11.3.1 Penetration Rate.160
11.4 DRIVERS AND LIMITERS ..162
11.4.1 Market Drivers .162
11.4.2 Market Limiters 163
11.5 COMPETITIVE ANALYSIS .164
CORONARY THROMBECTOMY DEVICE MARKET.167
12.1 INTRODUCTION 167
12.1.1 Drug-Eluting Stents and Thrombosis Treatment.167
12.2MARKET ANALYSIS & FORECAST ..168
12.2.1 Penetration Rate.170
12.3 DRIVERS AND LIMITERS ..172
12.3.1 Market Drivers .172
12.3.2 Market Limiters 172
12.4 COMPETITIVE ANALYSIS .174
CORONARY CHRONIC TOTAL OCCLUSION CROSSER MARKET .178
13.1 INTRODUCTION 178
13.2MARKET ANALYSIS & FORECAST ..179
13.2.1 Penetration Rate.182
13.2.2 Potential Market.184
13.3 DRIVERS AND LIMITERS ..186
13.3.1 Market Drivers .186
13.3.2 Market Limiters 187
13.4 COMPETITIVE ANALYSIS .188
INTRODUCER SHEATH MARKET191
14.1 INTRODUCTION 191
14.2MARKET OVERVIEW.192
14.3MARKET ANALYSIS & FORECAST ..195
14.3.1 Standard Introducer Sheath Market..197
14.3.2 Micro-Introducer Sheath Market 199
14.4 DRIVERS AND LIMITERS ..201
14.4.1 Market Drivers .201
14.4.2 Market Limiters 201
14.5 COMPETITIVE ANALYSIS .203
CO
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. U.S Market for Dental Prosthetics and CAD/CAM Devices
2. European Wound and Tissue Management Markets
3. Brazilian Market for Wound and Tissue Management
4. Briefing: Leading Pharma Companies to Watch in Todays Market Session
5. European Markets for Minimally Invasive Spinal Devices
6. Brazil Ophthalmic Devices Market Outlook to 2018 - Vision Care, Intraocular Lens (IOL), Cataract Surgery Devices, Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vitreo Retinal Surgery Devices and Others
7. United Kingdom Ophthalmic Devices Market Outlook to 2018 - Vision Care, Intraocular Lens (IOL), Cataract Surgery Devices, Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vitreo Retinal Surgery Devices and Others
8. India Wound Care Management Market Outlook to 2018 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices, Ostomy Drainage Bags and Others
9. The Market for Squamous Cell Carcinoma of the Head and Neck is Characterized by High Unmet Need of Treatment Options Based on Specific Tumor Biology
10. Wacoms DTH-2242: An Ideal Interactive Pen and Touch Display Solution for Healthcare and Presentation Markets
11. Millennium Research Group Identifies the Top Ten Trends in Medical Device Markets for 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... -- The Association of periOperative Registered Nurses (AORN) has awarded ... Stop and Go Sign designed by Christopher ... M.D., anesthesia providers with Anaesthesia Associates of Massachusetts ... is distributed by the Plexus Management Group, Inc. ... compliance with the AORN Safe Surgery Checklist. ...
(Date:5/5/2015)... , May 5, 2015 Merrimack Pharmaceuticals, ... of a randomized, double-blinded, placebo-controlled Phase 2 clinical ... and ErbB3, in combination with nab-paclitaxel and gemcitabine, ... newly-diagnosed metastatic pancreatic cancer who have high serum ... is the fourth leading cause of cancer death ...
(Date:5/5/2015)... May 5, 2015   Cynosure, Inc. (Nasdaq: ... devices for aesthetic procedures and precision surgical applications worldwide, ... March 31, 2015. First-Quarter Highlights: , ... , Non-GAAP earnings of $0.15 per share; GAAP earnings ... at March 31, 2015 "Cynosure delivered 21 ...
Breaking Medicine Technology:The Preoperative Stop and Go Sign Interactive Checklist Awarded AORN Seal of Recognition 2The Preoperative Stop and Go Sign Interactive Checklist Awarded AORN Seal of Recognition 3Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Front-line Clinical Trial of MM-141 in Biomarker-Selected Patients with Metastatic Pancreatic Cancer 2Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Front-line Clinical Trial of MM-141 in Biomarker-Selected Patients with Metastatic Pancreatic Cancer 3Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Front-line Clinical Trial of MM-141 in Biomarker-Selected Patients with Metastatic Pancreatic Cancer 4Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 2Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 3Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 4Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 5Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 6Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 7Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 8Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 9Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 10Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 11
... today-, SAN CARLOS, Calif., March 17 Nuvelo, ... the Phase 2 program in,catheter occlusion (CO), known as ... Alfimeprase), did not,show sufficient improvement in catheter opening at ... meet the desired target product,profile. As a result, Nuvelo ...
... Findings, BEDMINSTER, N.J., March 17 NPS,Pharmaceuticals, ... top-line,results from a 28-week blinded Phase 3-extension study ... who are dependent,upon parenteral nutrition (PN). The extension ... had completed a 24-week randomized Phase 3 study ...
Cached Medicine Technology:Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development 2Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development 3Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development 4NPS Reports Successful GATTEX(TM) Extension Study 2NPS Reports Successful GATTEX(TM) Extension Study 3NPS Reports Successful GATTEX(TM) Extension Study 4NPS Reports Successful GATTEX(TM) Extension Study 5
(Date:5/5/2015)... York, New York (PRWEB) May 05, 2015 ... lawsuits ( http://www.testosteronelawsuithub.com/ ) filed on behalf ... complications due to their use of prescription ... in the federal multidistrict litigation underway in ... According to court documents dated May 1st, ...
(Date:5/5/2015)... May 05, 2015 From the ... the established leader in enabling enterprise collaboration across ... help customers speed up and simplify the move ... AvePoint Solutions for Office 365 enable ... while ensuring sustainable user adoption and effectively managing ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Viverae®, ... C.R. Bard Inc., a leading multinational developer, manufacturer ... the fields of vascular, urology, oncology and surgical ... Vanguard Award. The Vanguard Award recognizes outstanding ... wellness programs among Viverae’s significant client base. , ...
(Date:5/5/2015)... York, NY (PRWEB) May 05, 2015 The newly ... on the experiences of Dr. Brad Reedy from his ... Judith Regan was asked why she chose to publish a parenting ... as a parent (and publisher) is the idea that it is ... we and our children are on the trek sometimes together and ...
(Date:5/5/2015)... 2015 Baptist Medical Center Jacksonville’s cancer ... (CoC) of the American College of Surgeons. , To ... more than 30 Commission on Cancer quality care standards, ... and maintain levels of excellence in the delivery of ... to seek care locally at a CoC-accredited cancer center, ...
Breaking Medicine News(10 mins):Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 3Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 4Health News:AvePoint Unveils New Solutions for Microsoft Office 365 & Azure at Microsoft Ignite 2015 2Health News:AvePoint Unveils New Solutions for Microsoft Office 365 & Azure at Microsoft Ignite 2015 3Health News:Viverae® Honors C. R. Bard, Inc. with 2015 Vanguard Award 2Health News:The Last Parenting Book You Will Ever Need: Veteran Publisher Judith Regan Releases A Provocative New Book By Dr. Brad Reedy, "The Journey Of The Heroic Parent" 2Health News:The Last Parenting Book You Will Ever Need: Veteran Publisher Judith Regan Releases A Provocative New Book By Dr. Brad Reedy, "The Journey Of The Heroic Parent" 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 2Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 4
... research facility in Toronto in Ontario Institute for Cancer ... The new research facility will act as a network ... will consist of // researchers from various Universities ... a team in providing new treatment methods for cancer. ...
... patients with whooping cough/Pertussis have tripled in Idaho (central) and ... infectious respiratory disease. 72 cases have been ... in Ada (55 cases), Boise, Elmore (17) and Valley counties ... are on the rise when compared to the 10 year ...
... published in the December issue of Arthritis and Rheumatism says ... a vital role in the pathogenesis of rheumatoid arthritis (RA), ... protein was found by a team of researchers at the ... of London. It appears that the protein modifies itself and ...
... Researchers at the Virginia Commonwealth University have found that ... periodontitis may be responsible for increasing the risk of ... ,Periodontitis is the inflammation of the supporting tissue that ... presence with a host of diseases including diabetes and ...
... has spread its wings over the Crimean peninsula. The cases have ... in the government as well as public. // ,To ... to determine if the virus is the deadly strain that has ... has been called for by the Ukrainian president in some parts ...
... health sector of England has both doctors and nurses of ... almost 20 percent.// The National Health Service (NHS) of ... Children's Hospital, in the Wellchild awards. ,Jaswant ... has been honoured in a national competition. Children's health charity ...
Cached Medicine News:Health News:Severe Gum Disease Triples Heart Disease Risk 2
... MIRAX SCAN is the system solution for digital ... monitor, a dual processor PC and software modules. ... scanner, which makes the specimens available as Digital ... quality, with the same optical resolution as on ...
... 1400 Series Biosafety Cabinets ... revolutionize working in a ... most comfortable, quiet, and ... cabinet on the market, ...
... Designed for ease of use and patient ... smooth edges for comfort and is available ... to a perfect fit. For hard to ... trach collar to your specifications. Don't just ...
Velcro® Tracheostomy tube holders are available in Adult, pediatric, and infant sizes....
Medicine Products: